AU573390B2 - Furo(3,2-c)pyridine derivatives - Google Patents
Furo(3,2-c)pyridine derivativesInfo
- Publication number
- AU573390B2 AU573390B2 AU47952/85A AU4795285A AU573390B2 AU 573390 B2 AU573390 B2 AU 573390B2 AU 47952/85 A AU47952/85 A AU 47952/85A AU 4795285 A AU4795285 A AU 4795285A AU 573390 B2 AU573390 B2 AU 573390B2
- Authority
- AU
- Australia
- Prior art keywords
- compound
- formula
- group
- hydrogen
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
- Mushroom Cultivation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8414842A FR2570701B1 (fr) | 1984-09-27 | 1984-09-27 | Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique |
| FR8414842 | 1984-09-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU4795285A AU4795285A (en) | 1986-04-10 |
| AU573390B2 true AU573390B2 (en) | 1988-06-09 |
Family
ID=9308136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU47952/85A Ceased AU573390B2 (en) | 1984-09-27 | 1985-09-27 | Furo(3,2-c)pyridine derivatives |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4661498A (enExample) |
| EP (1) | EP0178201B1 (enExample) |
| JP (1) | JPS61106577A (enExample) |
| KR (1) | KR860002508A (enExample) |
| AT (1) | ATE40554T1 (enExample) |
| AU (1) | AU573390B2 (enExample) |
| CA (1) | CA1291994C (enExample) |
| DE (1) | DE3568045D1 (enExample) |
| DK (1) | DK158953C (enExample) |
| ES (1) | ES8605522A1 (enExample) |
| FI (1) | FI82054C (enExample) |
| FR (1) | FR2570701B1 (enExample) |
| GR (1) | GR852356B (enExample) |
| HU (1) | HU192365B (enExample) |
| IL (1) | IL76535A0 (enExample) |
| NO (1) | NO162821C (enExample) |
| NZ (1) | NZ213620A (enExample) |
| PT (1) | PT81206B (enExample) |
| ZA (1) | ZA857457B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2566775B1 (fr) * | 1984-06-27 | 1986-10-31 | Synthelabo | Derives de tetrahydro-4,5,6,7 furo ou 1h-pyrrolo(2,3-c)pyridine, leur preparation et leur application en therapeutique |
| FR2619112B1 (fr) * | 1987-08-07 | 1989-11-17 | Synthelabo | Derives de (piperidinyl-4)methyl-2 benzo(b)furo(2,3-c) pyridines, leur preparation et leur application en therapeutique |
| FR2635977B1 (fr) * | 1988-09-07 | 1992-05-15 | Synthelabo | Utilisation de derives de tetrahydro-4,5,6,7 furopyridines pour obtenir des medicaments destines au traitement de l'obesite |
| US5795784A (en) | 1996-09-19 | 1998-08-18 | Abbott Laboratories | Method of performing a process for determining an item of interest in a sample |
| US5856194A (en) | 1996-09-19 | 1999-01-05 | Abbott Laboratories | Method for determination of item of interest in a sample |
| UA52681C2 (uk) * | 1997-04-08 | 2003-01-15 | Янссен Фармацевтика Н.В. | Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі |
| UA70334C2 (en) * | 1998-10-06 | 2004-10-15 | Janssen Pharmaceutica N V Jans | BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS |
| JP4717216B2 (ja) | 1998-12-21 | 2011-07-06 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | α２−アンタゴニストとしてのベンズイソキサゾールおよびフェノン類 |
| NZ512289A (en) | 1999-01-19 | 2003-06-30 | Neurosearch As | Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2215948B1 (enExample) * | 1973-02-01 | 1976-05-14 | Centre Etd Ind Pharma | |
| DD210278A5 (de) * | 1982-03-05 | 1984-06-06 | Boehringer Ingelheim Kg | Verfahren zur herstellung neuer basisch substituierter 4-phenyl-4,5,6,7-tetrahydro-thieno-(2,3-c)pyridine |
-
1984
- 1984-09-27 FR FR8414842A patent/FR2570701B1/fr not_active Expired
-
1985
- 1985-09-06 AT AT85401732T patent/ATE40554T1/de not_active IP Right Cessation
- 1985-09-06 DE DE8585401732T patent/DE3568045D1/de not_active Expired
- 1985-09-06 EP EP85401732A patent/EP0178201B1/fr not_active Expired
- 1985-09-26 ZA ZA857457A patent/ZA857457B/xx unknown
- 1985-09-26 US US06/780,453 patent/US4661498A/en not_active Expired - Fee Related
- 1985-09-26 DK DK435285A patent/DK158953C/da not_active IP Right Cessation
- 1985-09-26 FI FI853719A patent/FI82054C/fi not_active IP Right Cessation
- 1985-09-26 PT PT81206A patent/PT81206B/pt not_active IP Right Cessation
- 1985-09-26 NZ NZ213620A patent/NZ213620A/en unknown
- 1985-09-26 HU HU853694A patent/HU192365B/hu not_active IP Right Cessation
- 1985-09-26 NO NO853782A patent/NO162821C/no unknown
- 1985-09-26 GR GR852356A patent/GR852356B/el unknown
- 1985-09-26 CA CA000491635A patent/CA1291994C/en not_active Expired - Fee Related
- 1985-09-26 JP JP60214460A patent/JPS61106577A/ja active Pending
- 1985-09-26 ES ES547315A patent/ES8605522A1/es not_active Expired
- 1985-09-26 KR KR1019850007089A patent/KR860002508A/ko not_active Ceased
- 1985-09-27 AU AU47952/85A patent/AU573390B2/en not_active Ceased
- 1985-09-29 IL IL76535A patent/IL76535A0/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU4795285A (en) | 1986-04-10 |
| HU192365B (en) | 1987-05-28 |
| NO853782L (no) | 1986-04-01 |
| EP0178201A1 (fr) | 1986-04-16 |
| NO162821C (no) | 1990-02-21 |
| ZA857457B (en) | 1986-05-28 |
| PT81206B (pt) | 1988-01-22 |
| DK158953B (da) | 1990-08-06 |
| NO162821B (no) | 1989-11-13 |
| DK435285D0 (da) | 1985-09-26 |
| FI82054B (fi) | 1990-09-28 |
| DK435285A (da) | 1986-03-28 |
| PT81206A (fr) | 1985-10-01 |
| ES547315A0 (es) | 1986-03-16 |
| DK158953C (da) | 1991-01-14 |
| DE3568045D1 (en) | 1989-03-09 |
| HUT38945A (en) | 1986-07-28 |
| CA1291994C (en) | 1991-11-12 |
| ATE40554T1 (de) | 1989-02-15 |
| US4661498A (en) | 1987-04-28 |
| FR2570701B1 (fr) | 1987-05-22 |
| FI853719L (fi) | 1986-03-28 |
| EP0178201B1 (fr) | 1989-02-01 |
| JPS61106577A (ja) | 1986-05-24 |
| NZ213620A (en) | 1988-01-08 |
| ES8605522A1 (es) | 1986-03-16 |
| KR860002508A (ko) | 1986-04-26 |
| IL76535A0 (en) | 1986-02-28 |
| GR852356B (enExample) | 1986-01-28 |
| FI853719A0 (fi) | 1985-09-26 |
| FI82054C (fi) | 1991-01-10 |
| FR2570701A1 (fr) | 1986-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU560028B2 (en) | Pyridine-n-oxide derivatives | |
| NO863823L (no) | 1,5-benzothiazepinderivater som er anvendelige som utgangsmaterialer ved fremstilling av nye, terapeutisk aktive 8-klor-1,5-benzothiazepinderivater, og fremgangsmaate ved deres fremstilling. | |
| IE38801L (en) | Piperidine derivatives. | |
| AU1433588A (en) | 1-phenyl-3-naphthalenyloxypropanamines | |
| AU2201088A (en) | 1-((2-pyrimidinyl)aminoalkyl)piperidines, their preparation and their application in therapy | |
| AU576449B2 (en) | Nicotinic acid derivatives | |
| AU553859B2 (en) | Tricyclic oxindole carboxamides | |
| AU7946287A (en) | Oxadiazole-alkyl-purine derivatives | |
| AU4795285A (en) | Furo(3,2-c)pyridine derivatives | |
| AU569787B2 (en) | Tetrahydrothienopyridines | |
| AU586086B2 (en) | 1,5-benzothiazepine derivatives, their preparation and compositions containing them | |
| ES2000907A6 (es) | Procedimiento de preparar compuestos 2-oxaisocefen microbiologicamente activos | |
| IE890092L (en) | Process for preparing hydroxyalkylating agents, the agents so obtained, and their use | |
| AU6624281A (en) | 2,3-dihydro-imidazo(1,2-g)pyridazine derivatives | |
| AU588656B2 (en) | New fluorine-containing 1,4-dihydropyridines, process for their preparation and their use as medicaments | |
| AU588414B2 (en) | Methionine-substituted 1, 4-dihydropyridines, process for the preparation and their use | |
| ES8704897A1 (es) | Procedimiento para la obtencion de 1,4-dihidropiridinas | |
| AU4209693A (en) | Novel piperidine derivatives and process for preparation thereof | |
| IE881752L (en) | New aminoacylates of glycerol acetal | |
| CS902588A2 (en) | Method of 2-aminotetrahydroisoquinoline derivatives production | |
| DK74594A (da) | Fremgangsmåde til fremstilling af paroxetin eller et farmaceutisk acceptabelt salt deraf |